| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.0005 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.24 | 0.001 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.002 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.008 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.13 | 0.04 |